The risk of venous thromboembolism in patients with heart failure

Aim. To quantify the risk of venous thromboembolism (VTE) in hospitalized patients, depending on the severity of heart failure (HF).Material and methods. Current cross-sectional study included 132 patients hospitalized in the cardiology department in 2019. All participants were divided into 2 groups...

Full description

Bibliographic Details
Main Authors: N. K. Vereina, D. G. Agasyan, V. S. Chulkov
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC  2020-02-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/3678
id doaj-3484ad9ef1cc41e8b6dae669ed4a2eb5
record_format Article
spelling doaj-3484ad9ef1cc41e8b6dae669ed4a2eb52021-07-28T14:02:38Zrus«FIRMA «SILICEA» LLC Российский кардиологический журнал1560-40712618-76202020-02-0125110.15829/1560-4071-2020-1-36782825The risk of venous thromboembolism in patients with heart failureN. K. Vereina0D. G. Agasyan1V. S. Chulkov2South Ural State Medical UniversitySouth Ural State Medical UniversitySouth Ural State Medical UniversityAim. To quantify the risk of venous thromboembolism (VTE) in hospitalized patients, depending on the severity of heart failure (HF).Material and methods. Current cross-sectional study included 132 patients hospitalized in the cardiology department in 2019. All participants were divided into 2 groups: group 1 (n=48) — patients with class I-II HF; group 2 (n=84) — patients with class III-IV HF. A total quantitative assessment of the VTE risk was carried out according to the Caprini risk scoring method.Results. All patients hospitalized in the cardiology department, regardless of HF class, had a moderate and high risk of VTE and required prophylactic anticoagulation. High VTE risk had 85% of patients with class I-II HF; 97,6% — patients with a class III-IV HF. Mean score of ≥10 was observed in every fifth patient. Atrial fibrillation requiring long-term anticoagulant therapy was observed in 51,5% of patients. There were no absolute contraindications for parenteral prophylactic anticoagulation at the time of hospitalization in the study population.Conclusion. All patients admitted to the cardiology department had a moderate and high according to the Caprini risk score, regardless of HF class. More than half of the patients had indications for long-term anticoagulant therapy. The remaining patients required the parenteral prophylactic anticoagulation.https://russjcardiol.elpub.ru/jour/article/view/3678heart failurevenous thromboembolismprevention
collection DOAJ
language Russian
format Article
sources DOAJ
author N. K. Vereina
D. G. Agasyan
V. S. Chulkov
spellingShingle N. K. Vereina
D. G. Agasyan
V. S. Chulkov
The risk of venous thromboembolism in patients with heart failure
Российский кардиологический журнал
heart failure
venous thromboembolism
prevention
author_facet N. K. Vereina
D. G. Agasyan
V. S. Chulkov
author_sort N. K. Vereina
title The risk of venous thromboembolism in patients with heart failure
title_short The risk of venous thromboembolism in patients with heart failure
title_full The risk of venous thromboembolism in patients with heart failure
title_fullStr The risk of venous thromboembolism in patients with heart failure
title_full_unstemmed The risk of venous thromboembolism in patients with heart failure
title_sort risk of venous thromboembolism in patients with heart failure
publisher «FIRMA «SILICEA» LLC 
series Российский кардиологический журнал
issn 1560-4071
2618-7620
publishDate 2020-02-01
description Aim. To quantify the risk of venous thromboembolism (VTE) in hospitalized patients, depending on the severity of heart failure (HF).Material and methods. Current cross-sectional study included 132 patients hospitalized in the cardiology department in 2019. All participants were divided into 2 groups: group 1 (n=48) — patients with class I-II HF; group 2 (n=84) — patients with class III-IV HF. A total quantitative assessment of the VTE risk was carried out according to the Caprini risk scoring method.Results. All patients hospitalized in the cardiology department, regardless of HF class, had a moderate and high risk of VTE and required prophylactic anticoagulation. High VTE risk had 85% of patients with class I-II HF; 97,6% — patients with a class III-IV HF. Mean score of ≥10 was observed in every fifth patient. Atrial fibrillation requiring long-term anticoagulant therapy was observed in 51,5% of patients. There were no absolute contraindications for parenteral prophylactic anticoagulation at the time of hospitalization in the study population.Conclusion. All patients admitted to the cardiology department had a moderate and high according to the Caprini risk score, regardless of HF class. More than half of the patients had indications for long-term anticoagulant therapy. The remaining patients required the parenteral prophylactic anticoagulation.
topic heart failure
venous thromboembolism
prevention
url https://russjcardiol.elpub.ru/jour/article/view/3678
work_keys_str_mv AT nkvereina theriskofvenousthromboembolisminpatientswithheartfailure
AT dgagasyan theriskofvenousthromboembolisminpatientswithheartfailure
AT vschulkov theriskofvenousthromboembolisminpatientswithheartfailure
AT nkvereina riskofvenousthromboembolisminpatientswithheartfailure
AT dgagasyan riskofvenousthromboembolisminpatientswithheartfailure
AT vschulkov riskofvenousthromboembolisminpatientswithheartfailure
_version_ 1721268883400163328